Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2024 Earnings Call Transcript
November 4, 2024Supernus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.06, expectations were $0.39.
KYW Radio Philadelphia on MSN3h
Medical Report: ADHD is well-documented in children, but what about adults?
ADHD is well-documented in children, but what about adults? A new report says more studies are needed. KYW medical editor Dr. Brian McDonough has more.
unilad20h
Children with high IQ scores are more likely to be diagnosed with ADHD later in life according to new study
A new study has indicated that children with high IQ scores are more likely to be diagnosed with ADHD later in life.